Overview
Title
To prohibit taxpayer-funded gender transition procedures, and for other purposes.
ELI5 AI
H.R. 2202 is a rule that stops the government from using taxpayer money to pay for medical changes for people changing from a boy to a girl or vice versa, but people can still pay for these changes with their own money.
Summary AI
H.R. 2202 is a bill that aims to stop federal taxpayer money from being used for gender transition procedures. It prohibits the use of federal funds for health plans or services that cover such procedures and ensures that federal healthcare facilities and employees do not provide these services. The bill allows individuals or states to use their own non-federal funds to cover gender transition procedures but does not interfere with private insurance or personal spending. It also amends the Affordable Care Act to prevent tax credits or cost-sharing reductions from being applied to plans covering gender transition procedures.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
Summary of the Bill
The proposed bill titled "End Taxpayer Funding of Gender Experimentation Act of 2025" aims to prohibit the use of federal funds for gender transition procedures. This ban extends to federally provided health insurance plans and services provided by federal facilities and employees. The bill also modifies the Affordable Care Act to disallow federal tax credits and cost-sharing reductions for plans including gender transition procedures while maintaining an option for individuals to purchase separate coverage using private funds.
Significant Issues
The bill raises several critical concerns. First and foremost, it restricts access to healthcare for transgender individuals by prohibiting taxpayer-funded support for gender transition-related services. This lack of support could disproportionately affect those who rely on federal assistance for healthcare, effectively limiting access to necessary medical procedures.
Language used in the bill, such as terms like "gender experimentation" and narrowly defined categories of "male" and "female," might come across as politically charged or misleading. This language could influence public perception and policy interpretations in ways that might not accurately reflect the bill's practical implications.
The bill lacks clear definitions for many key terms, potentially leading to varied interpretations and legal challenges. Definitions such as "gender transition procedures" encompass a wide range of medical services, and the absence of clear guidelines can result in confusion about what services are prohibited.
Broad Public Impact
This bill can have wide-ranging effects on the general public, particularly in limiting federal support for gender transition procedures. Such restrictions might lead to significant health and social implications for transgender individuals, impacting their ability to access necessary medical care through public funds.
Additionally, by preventing federal funds from being used for these procedures, the bill could increase health disparities within the transgender community. Transgender individuals already face numerous healthcare challenges, and the bill may exacerbate these issues by removing vital financial support options.
Impact on Specific Stakeholders
Transgender Individuals
Transgender people are likely to be the most directly affected by this legislation, facing restricted access to necessary medical care and potential increased healthcare costs if they are unable to receive federal support for gender transition procedures.
Healthcare Providers
Healthcare professionals providing gender-affirming care through federal facilities might encounter operational challenges given the bill's restrictions. They may need to navigate complex legal landscapes to continue offering these services, potentially under separate, private arrangements.
Federal Programs and State Governments
Federal programs, such as Medicaid, and state governments will be challenged to adjust their healthcare offerings to align with this bill's prohibitions. There might be administrative burdens and confusion about compliance, particularly concerning funding mechanisms and separate coverage impacts.
Insurance Companies
Some insurers could view the bill positively, as it allows the separation of specific coverage types, opening the market for privately funded plans specific to gender transition procedures. However, they will also need to adapt offerings to comply with federal funding restrictions.
In conclusion, while aiming to restrict federal expenditure, the bill could have profound implications for both the healthcare system and transgender individuals' access to necessary care, raising ethical and economic considerations.
Issues
The prohibition of taxpayer-funded gender transition procedures, without clear definitions or exceptions for medical necessity, might limit access to essential healthcare for transgender individuals, raising ethical and health concerns (Sections 101, 301, 302).
The language used in the bill, particularly the use of terms like 'gender experimentation' and definitions of 'male' and 'female,' may be considered politically charged and potentially misleading, impacting public perception and interpretation of the bill (Section 1, Section 307).
The bill prohibits taxpayer funding for gender transition procedures through federal facilities and employees, but lacks clarity in defining 'gender transition procedures,' potentially leading to varying interpretations and legal disputes (Section 303).
The exclusion for individuals with 'disorders of sex development' requires detailed and potentially contentious determination processes, risking inconsistent application and possible discrimination (Section 307).
The use of non-Federal funds for health coverage and the concept of 'separate coverage' are not clearly defined, causing potential confusion about compliance and application, particularly with Medicaid and federally subsidized programs (Sections 304, 305).
The amendments to the Affordable Care Act's provisions regarding premium credits and cost-sharing reductions for plans covering gender transition procedures may lead to discrimination and lack of access to necessary healthcare due to complex cross-references and financial barriers (Section 201).
The language and definitions in the bill, particularly concerning 'gender transition procedures,' are overly complex and detailed, which might lead to misinterpretation or unintended exclusions of legitimate medical practices (Section 307).
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title; table of contents Read Opens in new tab
Summary AI
The first section of the bill provides the short title, "End Taxpayer Funding of Gender Experimentation Act of 2025," and outlines the table of contents, which includes Titles I and II. Title I addresses the prohibition of federally funded gender transition procedures, while Title II clarifies the application of this prohibition under the Affordable Care Act concerning premium credits and cost-sharing reductions.
101. Prohibiting taxpayer-funded gender transition procedures Read Opens in new tab
Summary AI
This section proposes a new chapter to the United States Code that would prohibit the use of federal funds for gender transition procedures or health plans covering them. It also sets definitions for terms like "gender transition" and outlines exceptions, such as medical treatments for disorders of sex development or procedures necessary to prevent death or major impairment.
301. Prohibition on funding for gender transition procedures Read Opens in new tab
Summary AI
The section states that no federal funds, including those in any trust funds, can be used for procedures related to gender transition.
302. Prohibition on funding for health benefits plans that cover gender transition procedures Read Opens in new tab
Summary AI
The section prohibits the use of federal funds for any health insurance plans that cover gender transition procedures, meaning government money cannot be spent on these services.
303. Limitation on Federal facilities and employees Read Opens in new tab
Summary AI
The section states that health care services provided by Federal Government facilities or employees cannot include gender transition procedures.
304. Construction relating to separate coverage Read Opens in new tab
Summary AI
Individuals, entities, and states or localities can buy separate health insurance that covers gender transition procedures as long as they use their own money and not federal funds or matching funds required for federally subsidized programs like Medicaid.
305. Construction relating to the use of non-Federal funds for health coverage Read Opens in new tab
Summary AI
Non-Federal health insurance providers can offer coverage for gender transition procedures, and states or localities can contract with these providers for such coverage, as long as they use funds that are not federally authorized or appropriated and do not use federally tied matching funds, like those for Medicaid.
306. Construction relating to complications arising from gender transition procedures Read Opens in new tab
Summary AI
The section states that the rules in this chapter do not cover the treatment of any medical issues, such as infections or injuries, that result from or worsen due to gender transition procedures.
307. Definitions Read Opens in new tab
Summary AI
This section defines key terms related to sex and gender, including “female” and “male” as individuals with specific reproductive systems, “gender transition” as the process of changing one’s gender identity, and “gender transition procedure” as hormonal or surgical interventions for this purpose. It also outlines exceptions where such procedures are not termed "gender transition," such as treatments for certain medical conditions or normalizing puberty.
102. Amendment to table of chapters Read Opens in new tab
Summary AI
The section changes the list of chapters in title 1 of the United States Code by adding a new chapter at the end. The new chapter is about prohibiting taxpayer money from being used for gender transition procedures and is titled "4. Prohibiting taxpayer-funded gender transition procedures 301."
201. Clarifying application of prohibition to premium credits and cost-sharing reductions under ACA Read Opens in new tab
Summary AI
The section amends the Internal Revenue Code and other laws to disallow federal tax credits or cost-sharing reductions for health plans that include gender transition procedures, while allowing the option to purchase or offer separate coverage for these procedures without using those credits. It also specifies that multi-State health plans should not use federal funds to cover gender transition procedures.